Shanghai Titan Stock Hits Day Low of CNY 21.88 Amid Price Pressure

Shanghai Titan Scientific Co., Ltd. experienced significant volatility on May 29, 2026, with the stock declining by 9.69% and reaching an intraday low of CNY 21.88. This performance starkly contrasts with the broader market, as the China Shanghai Composite index only fell by 0.73% on the same day. Over the past week, Shanghai Titan has seen a steep decline of 21.4%, while its monthly performance shows a decrease of 4.47%. Year-to-date, the stock has slightly underperformed with a decline of 0.63%. In the longer term, the company has faced substantial challenges, with a staggering 78.36% drop over the past three years and an 89.75% decline over five years. Financial metrics indicate ongoing difficulties, including a net sales drop of 7.31% and a pre-tax profit of CNY -1.67 million, reflecting a 60.06% decrease. The company has reported negative results for seven consecutive quarters, highlighting persistent operational struggles. With a market capitalization of CNY 3,680 million, Shanghai Titan continues to navigate a challenging landscape in the pharmaceuticals and biotechnology sector.